{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T03:10:25Z","timestamp":1768446625124,"version":"3.49.0"},"reference-count":51,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T00:00:00Z","timestamp":1737072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Major Program of Natural Science Foundation of Zhejiang","award":["LDT23H19013H19"],"award-info":[{"award-number":["LDT23H19013H19"]}]},{"name":"Major Program of Natural Science Foundation of Zhejiang","award":["WKJ-ZJ-2220"],"award-info":[{"award-number":["WKJ-ZJ-2220"]}]},{"name":"National Health Commission Scientific Research Projects","award":["LDT23H19013H19"],"award-info":[{"award-number":["LDT23H19013H19"]}]},{"name":"National Health Commission Scientific Research Projects","award":["WKJ-ZJ-2220"],"award-info":[{"award-number":["WKJ-ZJ-2220"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Despite the widespread use of COVID-19 vaccines, there is still a global need to find effective therapeutics to deal with the variants of SARS-CoV-2. Moslae herba (MH) is a herbal medicine credited with antiviral effects. This study aims to investigate the antiviral effects and the underlying mechanism of aqueous extract of Moslae herba (AEMH) for treating SARS-CoV-2. The in vitro anti-SARS-CoV-2 activity of AEMH was evaluated using cell viability and viral load. Component analysis was performed by HPLC-ESI-Q-TOF\/MS. The connection between COVID-19 and AEMH was constructed by integrating network pharmacology and transcriptome profiles to seek the core targets. The components with antiviral activities were analyzed by molecular docking and in vitro pharmacological verification. AEMH exerted anti-SARS-CoV-2 effects by inhibiting viral replication and reducing cell death caused by infection (IC50 is 170 \u03bcg\/mL for omicron strain). A total of 27 components were identified from AEMH. Through matching 119 intersection targets of \u2018disease and drug\u2019 with 1082 differentially expressed genes of COVID-19 patients, nine genes were screened. Of the nine, the PNP and TPI1 were identified as core targets as AEMH treatment significantly regulated the mRNA expression level of the two genes on infected cells. Three components, caffeic acid, luteolin, and rosmarinic acid, displayed antiviral activities in verification. Molecular docking also demonstrated they could form stable bonds with the core targets. This study explored the antiviral activity and possible mechanism of AEMH for treating SARS-CoV-2, which could provide basic data and reference for the clinical application of MH.<\/jats:p>","DOI":"10.3390\/molecules30020387","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T11:24:56Z","timestamp":1737113096000},"page":"387","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Antiviral Activity and Underlying Mechanism of Moslae herba Aqueous Extract for Treating SARS-CoV-2"],"prefix":"10.3390","volume":"30","author":[{"given":"Yan","family":"Feng","sequence":"first","affiliation":[{"name":"Key Laboratory of Public Health Detection and Etiological Research of Zhejiang Province, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Ge","sequence":"additional","affiliation":[{"name":"Key Laboratory of Public Health Detection and Etiological Research of Zhejiang Province, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Gao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Public Health Detection and Etiological Research of Zhejiang Province, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuoying","family":"Wu","sequence":"additional","affiliation":[{"name":"Zhejiang Key Lab of Vaccine, Infectious Disease Prevention and Control, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310015, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2863-5529","authenticated-orcid":false,"given":"Yunyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Zhejiang Key Lab of Vaccine, Infectious Disease Prevention and Control, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310015, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyan","family":"Mao","sequence":"additional","affiliation":[{"name":"Key Laboratory of Public Health Detection and Etiological Research of Zhejiang Province, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beibei","family":"Wu","sequence":"additional","affiliation":[{"name":"Zhejiang Key Lab of Vaccine, Infectious Disease Prevention and Control, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310015, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changping","family":"Xu","sequence":"additional","affiliation":[{"name":"Key Laboratory of Public Health Detection and Etiological Research of Zhejiang Province, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Hangzhou 310051, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,17]]},"reference":[{"key":"ref_1","unstructured":"Word Health Organization (WHO) (2024, November 17). WHO COVID-19 Dashboard. Available online: https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41579-024-01036-y","article-title":"COVID-19 drug discovery and treatment options","volume":"22","author":"Chan","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e134","DOI":"10.3346\/jkms.2024.39.e134","article-title":"Review of COVID-19 therapeutics by mechanism: From discovery to approval","volume":"39","author":"Choi","year":"2024","journal-title":"J. Korean Med. Sci."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An Oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-022-04594-4","article-title":"Antibody evasion properties of SARS-CoV-2 omicron sublineages","volume":"604","author":"Iketani","year":"2022","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0254-6272(15)30057-1","article-title":"Traditional Chinese medicine for the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials","volume":"34","author":"Wang","year":"2014","journal-title":"J. Tradit. Chin. Med."},{"key":"ref_8","first-page":"2925","article-title":"Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: A randomized, double blind, positive controlled clinical trial","volume":"18","author":"Duan","year":"2011","journal-title":"Chin. Med. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.explore.2021.12.005","article-title":"Integrated Chinese herbal medicine and western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report","volume":"19","author":"Hung","year":"2023","journal-title":"Explore"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.joim.2020.07.008","article-title":"Chinese herbal medicine for COVID-19: Current evidence with Systematic review and meta-analysis","volume":"18","author":"Fan","year":"2020","journal-title":"J. Integr. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s40001-023-01006-9","article-title":"The efficacy of traditional Chinese medicine in the treatment of the COVID-19 pandemic in Henan province: A retrospective study","volume":"28","author":"Han","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41586-022-05594-0","article-title":"FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2","volume":"615","author":"Brevini","year":"2023","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"He, M.F., Liang, J.H., Shen, Y.N., Zhang, J.W., Liu, Y., Yang, K.Y., Liu, L.C., Wang, J., Xie, Q., and Hu, C. (2022). Glycyrrhizin inhibits SARS-CoV-2 entry into cells by targeting ACE2. Life, 12.","DOI":"10.3390\/life12111706"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Qian, L., and Zeng, Z. (2024). Network-based pharmacology and UHPLC-Q-Exactive-Orbitrap-MS reveal Jinhua Qinggan granule\u2019s mechanism in reducing cellular inflammation in COVID-19. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1382524"},{"key":"ref_15","first-page":"122","article-title":"Treating 200 cases of cold of the Shushi type with Xinjia Xiangru Yin","volume":"26","author":"Yuan","year":"2018","journal-title":"Clin. J. Chin. Med."},{"key":"ref_16","first-page":"441","article-title":"Study of Chaihu-Xiangru decoction on acute upper respiratory infection in summer","volume":"4","author":"Yao","year":"2005","journal-title":"Mod. J. Integr. Tradit. Chin. W. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jep.2016.02.042","article-title":"Anti-H1N1 influenza effects and its possible mechanism of Huanglian Xiangru decoction","volume":"185","author":"Wu","year":"2016","journal-title":"J. Ethnopharmacol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Duan, Z.Y., Sun, Y.P., Wang, Z.B., and Kuang, H.X. (2024). Moslae Herba: Botany, traditional uses, phytochemistry, and pharmacology. Molecules, 29.","DOI":"10.3390\/molecules29081716"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"112641","DOI":"10.1016\/j.jep.2020.112641","article-title":"Moslea Herba flavonoids alleviated influenza A virus-induced pulmonary endothelial barrier disruption via suppressing NOX4\/NF-\u03baB\/MLCK pathway","volume":"253","author":"Yu","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.virusres.2016.04.021","article-title":"Antiviral activity of Luteolin against Japanese encephalitis virus","volume":"220","author":"Fan","year":"2016","journal-title":"Virus Res."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Dai, W., Bi, J., Li, F., Wang, S., Huang, X., Meng, X., Sun, B., Wang, D., Kong, W., and Jiang, C. (2019). Antiviral efficacy of flavonoids against Enterovirus 71 infection in vitro and in newborn mice. Viruses, 11.","DOI":"10.3390\/v11070625"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/s12985-020-01451-6","article-title":"Luteolin inhibits respiratory syncytial virus replication by regulating the MiR-155\/SOCS1\/STAT1 signaling pathway","volume":"17","author":"Wang","year":"2020","journal-title":"Virol. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"155020","DOI":"10.1016\/j.phymed.2023.155020","article-title":"Luteolin inhibits herpes simplex virus 1 infection by activating cyclic guanosine monophosphate-adenosine monophosphate synthase-mediated antiviral innate immunity","volume":"120","author":"Wang","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Munaf\u00f2, F., Donati, E., Brindani, N., Ottonello, G., Armirotti, A., and De Vivo, M. (2022). Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-14664-2"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e35029","DOI":"10.1097\/MD.0000000000035029","article-title":"Luteolin is a potential inhibitor of COVID-19: An in silico analysis","volume":"102","author":"Wang","year":"2023","journal-title":"Medicine"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00894-021-04833-x","article-title":"Luteolin: A blocker of SARS-CoV-2 cell entry based on relaxed complex scheme, molecular dynamics simulation, and metadynamics","volume":"27","author":"Shadrack","year":"2021","journal-title":"J. Mol. Model."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.immuni.2023.05.007","article-title":"Multi-omics blood atlas reveals unique features of immune and platelet responses to SARS-CoV-2 omicron breakthrough infection","volume":"56","author":"Wang","year":"2023","journal-title":"Immunity"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1055\/s-2008-1074558","article-title":"Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa","volume":"74","author":"Liu","year":"2008","journal-title":"Planta Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.fitote.2009.12.005","article-title":"Antiviral flavonoids from Mosla scabra","volume":"81","author":"Wu","year":"2010","journal-title":"Fitoterapia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"153804","DOI":"10.1016\/j.phymed.2021.153804","article-title":"Bioactive constituents of Mosla chinensis-Cv. Jiangxiangru ameliorate inflammation through MAPK signaling pathways and modify intestinal microbiota in DSS-induced colitis mice","volume":"93","author":"Wang","year":"2021","journal-title":"Phytomedicine"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Nguyen, H.T., Do, V.M., Phan, T.T., and Nguyen Huynh, D.T. (2023). The potential of ameliorating COVID-19 and sequelae from Andrographis paniculata via bioinformatics. Bioinform. Biol. Insights, 17.","DOI":"10.1177\/11779322221149622"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e32693","DOI":"10.1097\/MD.0000000000032693","article-title":"Exploration of Fuzheng Yugan mixture on COVID-19 based on network pharmacology and molecular docking","volume":"102","author":"Jiang","year":"2023","journal-title":"Medicine"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tsui, M., Biro, J., Chan, J., Min, W., Dobbs, K., Notarangelo, L.D., and Grunebaum, E. (2022). Purine nucleoside phosphorylase defciency induces p53-mediated intrinsic apoptosis in human induced pluripotent stem cell-derived neurons. Sci. Rep., 12.","DOI":"10.1038\/s41598-022-10935-0"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Tecle, E., Chhan, C.B., Franklin, L., Underwood, R.S., Hanna-Rose, W., and Troemel, E.R. (2021). The purine nucleoside phosphorylase pnp-1 regulates epithelial cell resistance to infection in C. elegans. PLoS Pathog., 17.","DOI":"10.1101\/2021.02.03.429531"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Sant\u2019Anna, I., Ar\u00eades, R.S., de Souza, W.C.P., Lessa, R.C.D.S., and de Moraes, M.C. (2025). Development of an immobilized Mycobacterium tuberculosis purine nucleoside phosphorylase platform for ligand fishing and inhibition assays. J. Pharm. Biomed. Anal., 254.","DOI":"10.1016\/j.jpba.2024.116576"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10875-020-00800-y","article-title":"A Case with Purine Nucleoside Phosphorylase Deficiency Suffering from Late-Onset Systemic Lupus Erythematosus and Lymphoma","volume":"40","author":"Hussain","year":"2020","journal-title":"J. Clin. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Yin, G.Q., Zeng, H.X., Li, Z.L., Chen, C., Zhong, J.Y., Xiao, M.S., Zeng, Q., Jiang, W.H., Wu, P.Q., and Zeng, J.M. (2021). Differential proteomic analysis of children infected with respiratory syncytial virus. Braz. J. Med. Biol. Res., 54.","DOI":"10.1590\/1414-431x20209850"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"197767","DOI":"10.1016\/j.virusres.2019.197767","article-title":"Antiviral activity of Sambucus FormosanaNakai ethanol extract and related phenolic acid constituents against human coronavirus NL63","volume":"273","author":"Weng","year":"2019","journal-title":"Virus Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"115243","DOI":"10.1016\/j.jep.2022.115243","article-title":"Inhibition of influenza virus replication by apiaceae plants, with special reference to Peucedanum japonicum (Sacna) constituents","volume":"292","author":"Kanazawa","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.antiviral.2018.04.008","article-title":"Caffeic acid inhibits HCV replication via induction of IFN\u03b1 antiviral response through P62-mediated keap1\/Nrf2 signaling pathway","volume":"154","author":"Shen","year":"2018","journal-title":"Antivir. Res."},{"key":"ref_41","first-page":"595","article-title":"Inhibition of multiplication of herpes simplex virus by caffeic acid","volume":"28","author":"Ikeda","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Saivish, M.V., Pacca, C.C., Da Costa, V.G., De Lima Menezes, G., Da Silva, R.A., Nebo, L., Da Silva, G.C.D., De Aguiar Milhim, B.H.G., Da Silva Teixeira, I., and Henrique, T. (2023). Caffeic acid has antiviral activity against Ilh\u00e9us virus in vitro. Viruses, 15.","DOI":"10.3390\/v15020494"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"153310","DOI":"10.1016\/j.phymed.2020.153310","article-title":"Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19","volume":"85","author":"Adem","year":"2021","journal-title":"Phytomedicine"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Liao, X., Xin, J., Yu, Z., Yan, W., Li, C., Cao, L., Zhang, H., and Wang, W. (2024). Unlocking the antiviral potential of rosmarinic acid against chikungunya virus via IL-17 signaling pathway. Front. Cell Infect. Microbiol., 14.","DOI":"10.3389\/fcimb.2024.1396279"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Hu, X., An, S., Chu, J., Liang, B., Liao, Y., Jiang, J., Lin, Y., Ye, L., and Liang, H. (2023). Potential inhibitors of monkeypox virus revealed by molecular modeling approach to viral DNA topoisomerase I. Molecules, 28.","DOI":"10.3390\/molecules28031444"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jmii.2022.04.012","article-title":"Rosmarinic acid interferes with influenza virus A entry and replication by decreasing GSK3\u03b2and phosphorylated AKT expression levels","volume":"55","author":"Jheng","year":"2022","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12985-019-1203-z","article-title":"Evaluation of the virucidal effects of rosmarinic acid against enterovirus 71 infection via in vitro and in vivo study","volume":"16","author":"Lin","year":"2019","journal-title":"Virol. J."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Li, Q., Zhou, X., Wang, W., Xu, Q., Wang, Q., and Li, J. (2024). Structural basis of rosmarinic acid inhibitory mechanism on SARS-CoV-2 main protease. Biochem. Biophys. Res. Commun., 724.","DOI":"10.1016\/j.bbrc.2024.150230"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"29267","DOI":"10.1039\/D1RA05268C","article-title":"Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights","volume":"11","author":"Elebeedy","year":"2021","journal-title":"RSC Adv."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Majrashi, T.A., El Hassab, M.A., Mahmoud, S.H., Mostafa, A., Wahsh, E.A., Elkaeed, E.B., Hassan, F.E., Eldehna, W.M., and Abdelgawad, S.M. (2024). In vitro biological evaluation and in silico insights into the antiviral activity of standardized olive leaves extract against SARS-CoV-2. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0301086"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Li, J., Li, X., Wang, E., Yang, J., Li, J., Huang, C., Zhang, Y., and Chen, K. (2022). Neutralizing antibodies against the SARS-CoV-2 delta and omicron BA.1 following homologous CoronaVac booster vaccination. Vaccines, 10.","DOI":"10.3390\/vaccines10122111"}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/2\/387\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:31:09Z","timestamp":1759919469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/30\/2\/387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,17]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["molecules30020387"],"URL":"https:\/\/doi.org\/10.3390\/molecules30020387","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,17]]}}}